Tag: holding company
Oncologix updates on earnings
April 16, 2015HME News Staff
LAFAYETTE, La. - Oncologix, a diversified medical holding company with operating divisions in medical devices, healthcare services and DME sales and distribution, expects to grow annualized revenues to $25 million by the end of 2015, it announced April 14. It also expects to achieve positive EBITDA of more than $2.6 million. “Our stock price does not accurately reflect the hard work and success of our operating activities and it remains severely undervalued,” CEO Wayne Erwin stated in...